Apr 05, 2012, 02.29 PM | Source: PTI
Under Handa''s leadership Pfizer India entered the branded generics market and grew in strength by mergers with Parke-Davis and Pharmacia and integration with Wyeth India, the company said.
Under Handa's leadership Pfizer India entered the branded generics market and grew in strength by mergers with Parke-Davis and Pharmacia and integration with Wyeth India, the company said.
Speaking on his decision, Handa said: "After twenty personally and professionally rewarding years at Pfizer, it''s time for me to begin a new chapter in my life."
Handa, who had also held the position of Chief Financial Officer, has been the Managing Director of the company for the last seven years, Pfizer Ltd said.
Headquartered in Mumbai headquartered firm Pfizer Ltd has over 2,300 employees and a manufacturing facility at Thane.
Scrips of Pfizer Ltd today closed at Rs 1,216.80 per share on BSE, down 1.36% from its previous close.
A top Finance Ministry official today deposed befo
Four emerging economies, including India and China
More than 1.8 million dead people are listed as ac
Yahoo Inc and its Asian partners, China's Alibaba
In another blow for beleaguered BlackBerry maker R
Apple Inc is in very active discussions at the boa
HeidelbergCement India has reported a sales turnov
Medi-Caps has reported a sales turnover of Rs 6.77